GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Dr. Agarwals Health Care Ltd
Dr. Agarwals Health Care Q1 FY27 Revenue from Operations up 26.0% YoY to ₹614 Crores
RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 04 Aug 2026, 01:58 PM IST  ·  BSE ID: a672eb2a-ebfe-4f84-b4a5-4d547899deaa
View Original BSE Filing (PDF)
💡
In Simple Terms
The company reported strong Q1 FY27 financial results and made several auditor appointments and plans a new subsidiary in Nigeria.
🤖 AI Summary
  • Dr. Agarwals Health Care approved Q1 FY27 unaudited consolidated results, with Revenue from Operations up 26.0% YoY to ₹614 Crores.
  • Total Income for Q1 FY27 increased by 23.9% YoY to ₹620 Crores, and Profit After Tax rose 44.6% YoY to ₹55 Crores.
  • M/s. S.R. Batliboi & Associates LLP appointed as Statutory Auditors until the 20th AGM, and KPMG as Internal Auditors for FY2026-27.
  • M/s. B Y & Associates re-appointed as Cost Auditors for FY2026-27.
  • The company is incorporating a wholly-owned step-down subsidiary in Nigeria, subject to regulatory approvals.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue From Operations Q1 FY27
₹614 Crores
26.0%
Total Income Q1 FY27
₹620 Crores
23.9%
EBITDA Q1 FY27
₹177 Crores
25.2%
Profit After Tax Q1 FY27
₹55 Crores
44.6%
Network Facilities as of June 30, 2026
304 facilities
🏢 How This Affects the Company
📈
Business Impact
Revenue from Operations increased by 26.0% YoY to ₹614 Crores, driven by the addition of 18 new facilities and 91,082 surgeries in Q1 FY27.
💰
Financial Impact
Profit After Tax grew by 44.6% YoY to ₹55 Crores, and EBITDA increased by 25.2% YoY to ₹177 Crores, indicating improved profitability.
⚙️
Operational Impact
The network expanded to 304 facilities by June 30, 2026, with 18 new facilities commissioned during the quarter, including 16 new surgical facilities.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this filing.
👤
Who Is Affected
All shareholders are affected by the strong Q1 FY27 financial performance and the company's strategic expansion plans in India and Africa.
🔍
Management Signal
Management is focused on driving revenue growth, operational expansion through new facilities, and enhancing profitability, alongside ensuring robust audit practices.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q2 FY27 unaudited financial results — check revenue and profit growth trends.
Progress on Nigeria subsidiary incorporation — monitor regulatory approvals and operational commencement.
Annual General Meeting details — review member approval for Statutory Auditor re-appointment.
LOW RISK The filing indicates strong financial performance and strategic expansion with no immediate risks identified.
💡 Investor Takeaway
Dr. Agarwals Health Care reported Q1 FY27 consolidated Revenue from Operations of ₹614 Crores, a 26.0% YoY increase, and Profit After Tax of ₹55 Crores, up 44.6% YoY. The company is expanding its network with 18 new facilities and establishing a subsidiary in Nigeria.
⚖️ Strengths & Concerns

✅ Positives

  • Q1 FY27 Revenue from Operations grew 26.0% YoY to ₹614 Crores, reflecting strong top-line performance.
  • Profit After Tax increased by 44.6% YoY to ₹55 Crores in Q1 FY27, demonstrating enhanced profitability.
📅 Company Track Record
In FY26, Dr. Agarwals Health Care reported a total income of INR 2,125 crores, marking a 20.9% YoY increase. The company's network reached 304 facilities by June 30, 2026, consistent with its expansion strategy.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What were Dr. Agarwals Health Care's consolidated Revenue from Operations for Q1 FY27?
Dr. Agarwals Health Care reported consolidated Revenue from Operations of ₹614 Crores for the quarter ended June 30, 2026, representing a 26.0% year-on-year growth.
What was the Profit After Tax for Dr. Agarwals Health Care in Q1 FY27?
The Profit After Tax for Dr. Agarwals Health Care in Q1 FY27 was ₹55 Crores, which is a 44.6% increase compared to the prior year period.
Who were appointed as the Statutory Auditors for Dr. Agarwals Health Care?
M/s. S.R. Batliboi & Associates LLP, Chartered Accountants, were appointed as the Statutory Auditors to hold office until the conclusion of the 20th Annual General Meeting of the Company.
What is Dr. Agarwals Health Care's plan for international expansion mentioned in the filing?
Dr. Agarwals Health Care plans to incorporate a wholly-owned step-down subsidiary in Nigeria, subject to receiving necessary regulatory approvals.
How many new facilities did Dr. Agarwals Health Care add in Q1 FY27?
Dr. Agarwals Health Care added 18 new facilities during Q1 FY27, bringing its total network to 304 facilities as of June 30, 2026.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.